Pulse Pharma Private Limited - Charges

Every charge - open or closed - that lenders have registered against Pulse Pharma Private Limited, with the most recent activity at the top.

1995-01-31 New Delhi, Delhi Active Unlisted Active Compliant
Connect MCP
Open charges
0
••••
Closed charges
5
••••
Total
5
••••
Top lenders
#LenderChargesAmount
1 Canara Bank 3 ••••
2 Icici Bank Limited 1 ••••
3 Citibank N.A 1 ••••
All charges (5) - latest first
Charge ID Charge holder Created Modified Satisfied Amount Status
10362949 Citibank N.A 05 Jun 2012 - 26 Aug 2016 •••• Closed
10123924 Canara Bank 23 Aug 2008 23 Jul 2009 14 Sep 2016 •••• Closed
10017922 Icici Bank Limited 16 May 2006 22 Dec 2009 25 Apr 2019 •••• Closed
80026887 Canara Bank 03 Nov 2005 23 Jul 2009 14 Sep 2016 •••• Closed
80026888 Canara Bank 29 Sep 1999 23 Jul 2009 14 Sep 2016 •••• Closed
Frequently Asked Questions - Charges & borrowings
What do "charges" mean for Pulse Pharma Private Limited?
Charges are registrable security interests-typically loans or credit facilities-filed with MCA against Pulse Pharma Private Limited (CIN: U74899DL1995PTC064858). They indicate assets or undertakings pledged to lenders or charge holders.
What is the difference between open and closed charges?
Open charges are active or not yet fully discharged; closed (or satisfied) charges are recorded as settled or released. Counts and amounts on this page follow the statuses shown in the charge list.
How should I read the open vs closed amounts?
Open and closed amounts summarise registrable amounts by status for quick comparison; individual rows may show charge-specific amounts, holders, and dates for verification.
Who are the "top lenders" or charge holders?
Top lenders group charge holders by bank or institution name and approximate exposure so you can see which lenders appear most prominently for Pulse Pharma Private Limited.
Where can I cross-check financial or ownership context?
Pair this Charges view with the Financial and Ownership sections on this company's V1 profile for loans in financial statements and cap table context alongside MCA charge filings.